OraSure Technologies, Inc. (OSUR) Stock

OraSure Technologies, Inc. (OSUR) is a Healthcare stock trading at $4.24 (as of 2026-06-18), with a market capitalization of $296.05M and a trailing P/E of -4.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

OraSure Technologies, Inc., through its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States and internationally. It operates in two segments—Diagnostics and Molecular Solutions—and offers tests such as OraQuick and InteliSwab, along with specimen collection devices for use with screening and confirmatory testing.

Valuation — source: SEC EDGAR (first-party)
Price	$4.24
Market Cap	$296.05M
P/E Ratio	-4.1
EV / EBITDA	-1.8
Price / Book	0.94
Price / Sales	2.62
DCF Value (model)	$-10.22
DCF Upside vs Price	-341.0%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$115.02M
Net Margin	-59.8%
Return on Equity	-24.0%
Current Ratio	5.46
Revenue Growth (YoY)	-38.1%
EPS Growth (YoY)	261.5%
FCF Growth (YoY)	-325.7%

Financial Health — source: SEC EDGAR
Altman Z-Score	2.58 (grey)

Valuation vs Sector & Industry
Stock P/E	-4.1
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-119.5%
vs Industry	-112.9%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	BlackRock, Inc. ($19.55M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Carrie Eglinton Manner
Employees	501
Country	US
IPO Date	1986-11-17

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.